top of page
AdobeStock_1869010813.jpeg

Case Studies

AdobeStock_202696215.jpeg
AdobeStock_130601530.jpeg

Advancing Chronic Wound Care with Amniotic Membrane Therapy

An educational case overview highlighting the role of advanced biologics in stalled wound healing.

67f660676c1437b658991c04_Rectangle (1).png

Supporting Chronic Wound Healing with SimpliMax® Amniotic Membrane Allograft

Chronic wounds that fail to progress with standard care can place patients at risk for complications and prolonged healing times. In these cases, advanced biologic therapies may play an important role in supporting the wound healing environment.

This educational case highlights the use of SimpliMax® Amniotic Membrane Allograft (Q4341) as part of a comprehensive wound care approach.

Case Summary

An adult patient presented with a chronic lower-extremity ulcer that had shown minimal improvement despite appropriate wound care, including debridement, moisture management, and offloading. Due to stalled healing, the care team introduced an advanced amniotic membrane allograft to support tissue repair.

Why SimpliMax Was Selected

SimpliMax is a dehydrated, dual-layer amnion membrane allograft derived from donated human placental tissue and processed aseptically. It is terminally sterilized using gamma irradiation to achieve a sterility assurance level (SAL) of 1 × 10⁻⁶ and is packaged as a sterile, single-use product.

The allograft is processed in compliance with FDA Current Good Tissue Practices and American Association of Tissue Banks (AATB) standards, providing clinicians with confidence in product safety and handling.

Treatment and Outcome

Following wound bed preparation, SimpliMax was applied according to standard clinical protocols and incorporated into the patient’s ongoing wound care plan. After application, the wound demonstrated:

  • Improved wound bed quality

  • Increased granulation tissue

  • Gradual reduction in wound size

  • Continued progression after prior stagnation

The patient tolerated treatment well, and no local complications were observed.

Key Takeaway

This case demonstrates how SimpliMax Amniotic Membrane Allograft may be a valuable adjunct in the management of chronic or non-healing wounds when conventional therapies alone are insufficient. When used appropriately, advanced biologic allografts can help support the body’s natural healing processes and promote consistent wound progression.

Educational Disclaimer:
This content is for educational purposes only. All patient information has been de-identified. This material does not constitute medical advice or clinical guidance.

If you want next steps, I can:

  • Optimize this further for specific keywords (DFU, chronic wounds, amniotic grafts, etc.)

  • Create a series of short case blogs using this same structure

  • Rewrite it to be manufacturer-neutral or clinician-facing

  • Add a compliant “Clinical Evidence” page layout

© 2025 NextGen Medical Solutions, LLC.

Established in 2023 in Las Vegas, NV

Disclaimer: NextGen Medical Solutions is a medical distribution company and does not provide direct patient care. All wound care treatments are administered by licensed healthcare professionals. We provide these providers with high-quality regenerative products to support and improve treatment outcomes.

bottom of page